S&P 500   3,091.84 (+0.16%)
DOW   27,691.49 (+0.00%)
QQQ   201.54 (+0.29%)
AAPL   261.81 (-0.15%)
FB   194.47 (+2.56%)
MSFT   147.07 (+0.66%)
GOOGL   1,297.21 (-0.08%)
AMZN   1,778.00 (+0.36%)
CGC   19.25 (-5.17%)
NVDA   209.61 (+0.69%)
MU   46.90 (+1.38%)
BABA   186.97 (+0.14%)
GE   11.42 (+0.62%)
TSLA   349.93 (+1.40%)
T   39.17 (-0.51%)
AMD   36.71 (+1.10%)
F   9.04 (-0.44%)
ACB   3.57 (-1.38%)
PRI   129.95 (+0.56%)
NFLX   292.01 (-0.74%)
BAC   33.09 (-0.27%)
GILD   64.32 (-0.50%)
DIS   138.58 (+1.35%)
S&P 500   3,091.84 (+0.16%)
DOW   27,691.49 (+0.00%)
QQQ   201.54 (+0.29%)
AAPL   261.81 (-0.15%)
FB   194.47 (+2.56%)
MSFT   147.07 (+0.66%)
GOOGL   1,297.21 (-0.08%)
AMZN   1,778.00 (+0.36%)
CGC   19.25 (-5.17%)
NVDA   209.61 (+0.69%)
MU   46.90 (+1.38%)
BABA   186.97 (+0.14%)
GE   11.42 (+0.62%)
TSLA   349.93 (+1.40%)
T   39.17 (-0.51%)
AMD   36.71 (+1.10%)
F   9.04 (-0.44%)
ACB   3.57 (-1.38%)
PRI   129.95 (+0.56%)
NFLX   292.01 (-0.74%)
BAC   33.09 (-0.27%)
GILD   64.32 (-0.50%)
DIS   138.58 (+1.35%)
Log in

Forward Pharma A/S Stock Price, Forecast & Analysis (NASDAQ:FWP)

$0.88
-0.01 (-1.12 %)
(As of 11/12/2019 04:00 PM ET)
Today's Range
$0.87
Now: $0.88
$0.88
50-Day Range
$0.87
MA: $0.94
$1.02
52-Week Range
$0.71
Now: $0.88
$1.64
Volume4,300 shs
Average Volume18,610 shs
Market Capitalization$41.52 million
P/E RatioN/A
Dividend YieldN/A
Beta2.3
Forward Pharma A/S operates as a biopharmaceutical company. The company focuses on developing FP187, a proprietary formulation of dimethyl fumarate used for the treatment of various inflammatory and neurological indications. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:FWP
CUSIPN/A
Phone0114533444242

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.25 billion
Book Value$1.74 per share

Profitability

Miscellaneous

Employees5
Market Cap$41.52 million
Next Earnings Date11/28/2019 (Estimated)
OptionableNot Optionable

Receive FWP News and Ratings via Email

Sign-up to receive the latest news and ratings for FWP and its competitors with MarketBeat's FREE daily newsletter.


Forward Pharma A/S (NASDAQ:FWP) Frequently Asked Questions

What is Forward Pharma A/S's stock symbol?

Forward Pharma A/S trades on the NASDAQ under the ticker symbol "FWP."

How were Forward Pharma A/S's earnings last quarter?

Forward Pharma A/S (NASDAQ:FWP) issued its quarterly earnings data on Thursday, September, 1st. The biotechnology company reported ($0.32) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.26) by $0.06. View Forward Pharma A/S's Earnings History.

When is Forward Pharma A/S's next earnings date?

Forward Pharma A/S is scheduled to release their next quarterly earnings announcement on Thursday, November 28th 2019. View Earnings Estimates for Forward Pharma A/S.

Has Forward Pharma A/S been receiving favorable news coverage?

News stories about FWP stock have been trending very negative on Tuesday, according to InfoTrie Sentiment. The research firm scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Forward Pharma A/S earned a coverage optimism score of -3.2 on InfoTrie's scale. They also gave news articles about the biotechnology company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for Forward Pharma A/S.

Who are some of Forward Pharma A/S's key competitors?

What other stocks do shareholders of Forward Pharma A/S own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Forward Pharma A/S investors own include Celldex Therapeutics (CLDX), MOTIF BIO PLC/S (MTFB), Micron Technology (MU), Gilead Sciences (GILD), Novavax (NVAX), Portola Pharmaceuticals (PTLA), SCYNEXIS (SCYX), Novartis (NVS), Broadcom (AVGO) and Cytori Therapeutics (CYTX).

Who are Forward Pharma A/S's key executives?

Forward Pharma A/S's management team includes the folowing people:
  • Mr. Florian Schonharting, Co-Founder & Chairman (Age 50)
  • Dr. Claus Bo Svendsen, CEO & Principal Financial Officer (Age 42)
  • Mr. Thomas Carbone, Principal Accounting Officer (Age 62)

How do I buy shares of Forward Pharma A/S?

Shares of FWP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Forward Pharma A/S's stock price today?

One share of FWP stock can currently be purchased for approximately $0.88.

How big of a company is Forward Pharma A/S?

Forward Pharma A/S has a market capitalization of $41.52 million and generates $1.25 billion in revenue each year. Forward Pharma A/S employs 5 workers across the globe.View Additional Information About Forward Pharma A/S.

What is Forward Pharma A/S's official website?

The official website for Forward Pharma A/S is http://www.forward-pharma.com/.

How can I contact Forward Pharma A/S?

Forward Pharma A/S's mailing address is OSTERGADE 24A 1, COPENHAGEN G7, 1100. The biotechnology company can be reached via phone at 0114533444242 or via email at [email protected]


MarketBeat Community Rating for Forward Pharma A/S (NASDAQ FWP)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  246 (Vote Outperform)
Underperform Votes:  180 (Vote Underperform)
Total Votes:  426
MarketBeat's community ratings are surveys of what our community members think about Forward Pharma A/S and other stocks. Vote "Outperform" if you believe FWP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FWP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/12/2019 by MarketBeat.com Staff

Featured Article: Dividend Achievers

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel